Ankit I. Mehta, MD
NeurosurgeryBiographical Info
Experience
Fellowship/Internship:
Instructor/Fellowship in Complex Spine and Spinal Oncology
The Johns Hopkins Hospital, Baltimore, MD
Fellowship in Stereotactic Radiosurgery
Duke University School of Medicine, Durham, NC
Residency:
Neurosurgery Chief Resident
Duke University School of Medicine, Durham, NC
Durham VA Medical Center, Durham, NC
Neurosurgy Residency
Duke University School of Medicine, Durham, NC
Education
Medical School
Harvard Medical School & Massachusetts Institute of Technology, Boston, MA
Certifications
Board Certified:
American Board of Neurological Surgery
Medical Licensure
Illinois
Indiana
Appointments
Academic:
- Assistant Professor Department of Neurosurgery
University of Illinois at Chicago - Associate Program Director, Neurosurgery Residency Program
Department of Neurosurgery, University of Illinois at Chicago - Director, Spinal Oncology
Department of Neurosurgery, University of Illinois at Chicago - Adjunct Professor, Orthopedic Surgery, University of Illinois at Chicago
- Adjunt Professor, Chemical Engineering, University of Illinois at Chicago
Clinical:
- Department of Neurosurgery, University of Illinois at Chicago
Hospital:
- University of Illinois Hospital and Health Sciences System
Achievements/Awards
- 21st Century Research & Education Grant. Cervical Spine Research Grant 2019
- NASS (North American Spine Society) “20 Under 40” Leaders in Spine Award 2019
Click here for SpineLine publication (see page 34) - Rising Star Award. University of Illinois College of Medicine. June 2019
- AOSpine 2019 Discovery and Innovation Award, June 2019-Present
Clinical Interests
- Spinal Cord Injury
- Neuro-Oncology
Research Website
- Mehta Lab at the University of Illinois at Chicago
https://rchiu6.wixsite.com/mehtalab
Research Interests
- Treatment of Spinal Cord Injury With Bone Marrow Mesenchymal Stem Cell Derived Exosomes
- Determining Efficacy and Toxicity of Magnetically Guided Nanoparticles for Intramedullary Spinal Tumors
- Exosomes from Hypoxic Preconditioned Bone Marrow Stem Cell Media for Acute Spinal Cord Injury
- Graphene ALS Biomarker
- Spinal Cord Injury Contusion Model and Kinematic Analysis
Selected Publications
- Denyer S, Bhimani AD, Patil SN, Mudreac A, Behbahani M, Mehta AI. Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database. Journal of Cancer Research and Clinical Oncology. 2019 Nov 19.
- Chiu RG, Murphy BE, Rosenberg D, Zhu A, Mehta AI. Association of For-Profit Hospital Ownership Status with Intracranial Hemorrhage Outcomes and Cost of Care. Journal of Neurosurgery. 2019 Nov 29:1-9.
- Minnema AJ, Mehta AI, Boling WW, Farhadi HF. SCING – Spinal Cord Injury Neuroprotection with Glyburide: A Pilot, Open-Label, Multi-Centre, Prospective Evaluation of Oral Glyburide in Patients with Acute Traumatic Spinal Cord Injury in the United States. British Medical Journal. Accepted.
- Bhimani AD, Selner AN, Patel JB, Hobbs JG, Esfahani DR, Behbahani M, Nikas D, Mehta AI. Pediatric Tethered Cord Release: An Epidemiological and Postoperative Complication Analysis. Journal of Spine Surgery. 2019 Sep;5(3):337-350.
- Venugopal I, Mehta AI, Linninger AA. Drug Delivery Applications of Nanoparticles in the Spine. Methods Mol Biol. 2020; 2059:121-143.
Categories: Department of Neurosurgery